This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,424.46, is for the delivery of Xolair 300 mg/2 ml autoinjector vials to support the medical supply needs of military healthcare facilities.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This specific award does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across various product categories and medical domains.
Generated 3/31/25, 9:39 AM